Biotium Expands Long-Standing Bioz Partnership, Leveraging AI-Powered Badges to Showcase Top Products
These interactive widgets dynamically showcase how Biotium's innovative products are being used in various applications, including molecular biology, immunology, and cell imaging. A key advantage of Biotium's Bioz integration has been the Vendor Stats Dashboard, which provides real-time insights into researcher behavior and citation trends. Eric Torres, Director of Marketing at Biotium, highlighted the impact of this data. 'It's fascinating to see which scientific articles are being read and clicked on the most by our users. The engagement data from Bioz aligns well with our best-selling products, reinforcing the value that researchers place on our reagents and dyes.'
Additionally, Biotium has seen strong engagement with the 'Read Article' functionality of Bioz Badges, allowing users to seamlessly access scientific papers citing their products. This feature has become a critical tool for researchers, increasing time spent on Biotium's website while fostering deeper interactions with its product catalog.
Dr. Karin Lachmi, Chief Revenue Officer and co-founder of Bioz, expressed, 'Biotium is an exceptional partner that fully embraces AI-powered citation insights to strengthen their market presence. Our strong partnership highlights the value of Bioz technology in driving engagement, increasing visibility, and helping researchers make data-driven purchasing decisions.'
Biotium's continued collaboration with Bioz reflects a shared commitment to innovation and scientific advancement. By embracing AI-driven solutions, Biotium is not only enhancing the researcher experience but is also setting a new standard for data transparency and product credibility in the industry.
About Bioz
Bioz is the world's most advanced AI search engine for scientific research, offering evidence-based product ratings and recommendations to guide scientists toward the most validated products for their discoveries. Bioz's solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.
Biotium is a leading life science reagent manufacturer and supplier devoted to providing high-quality and innovative fluorescent tools that fuel scientific discovery. Its collaborative team of experienced chemists and biologists, who are at the forefront of fluorescent dye design, apply chemistry-based principles toward producing solutions for unmet challenges in life science and medical research. Since its founding in 2001, Biotium has developed over 30 patented technologies that have been licensed out to leading life science technology companies worldwide.
Contact InformationDaniel Levitt CEO
SOURCE: Bioz, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
3 hours ago
- Business Insider
Morgans Reaffirms Their Buy Rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR)
Morgans analyst Derek Jellinek maintained a Buy rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh today and set a price target of A$2.86. The company's shares opened today at A$1.39. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Jellinek covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per Cochlear , and CSL. According to TipRanks, Jellinek has an average return of 6.3% and a 59.52% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh with a A$2.58 average price target, implying an 86.28% upside from current levels. In a report released yesterday, Bell Potter also maintained a Buy rating on the stock with a A$2.25 price target. The company has a one-year high of A$2.08 and a one-year low of A$0.82. Currently, EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has an average volume of 899K.
Yahoo
6 hours ago
- Yahoo
Trump's Pay-For-Play Chips Deal Generates Alarm and Optimism
(Bloomberg) -- President Donald Trump's controversial plan to take a cut of revenue from chip sales to China is leading to concerns that the US government will find new ways to start charging companies for a range of business activities with other countries. Experts and people familiar with the matter said the surprise deal, in which Nvidia Corp. and Advanced Micro Devices Inc. agreed to pay 15% of their revenues from Chinese AI chip sales to the US, potentially provides a path to enter the Chinese market despite severe export controls, tariffs and other trade barriers. The US-Canadian Road Safety Gap Is Getting Wider Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets The question that companies must now confront is whether the risk is worth taking. People familiar with the matter, who asked not to be identified discussing private deliberations, said companies are struggling to figure out what the president's order means for their future, especially given the unpredictable nature of Trump's decision-making. 'This is truly bizarre and unusual, and the troubling thing — beyond the individual instances of AMD and Nvidia — is the possibility that this will be expanded,' said Gary Hufbauer, a senior fellow at the Peterson Institute for International Economics. 'Everything is now 'national security,' according to the new definition, which means it's all subject to export licenses and then they give you a license based on your contribution.' There are concerns that US trade agencies could begin charging fees to companies every time there's a meeting to discuss tariffs, according to people familiar with the matter who asked not to be identified discussing private deliberations. The Commerce Department's Bureau of Industry and Security, which issues export licenses, wasn't consulted about the revenue deal, according to people familiar with the matter who asked not to be identified discussing private conversations. Trump administration officials defend the idea as a smart way to generate revenue for the US government and suggest it will extend well beyond the chips sector. 'I think we could see it in other industries over time,' Treasury Secretary Scott Bessent said in an interview with Bloomberg Television on Wednesday. 'I think right now this is unique, but now that we have the model and the beta tests, why not expand it?' Bessent defended the deal and rejected any national-security concerns around the decision to sell Nvidia's H20 chip to China — something that had been earlier barred for fear of giving China a boost in the artificial-intelligence race. 'There are no national security concerns here,' Bessent said. 'We would not sell any of the advanced chips. So, the H20, I don't know whether you'd say they're four, five, six levels down the chips stack.' Either way, the deal highlights how Trump has pushed to open a wave of new revenue streams including by taking ownership shares of companies or extracting higher fees to live or work in the US. The US is weighing sales of a so-called 'gold card' residency permit, it won a 'golden share' to have direct say over corporate actions by United States Steel Corp., and it's secured investment pledges and potential revenue-sharing in country-level tariff talks. That's aside from the barrage of product tariffs that have at times left massive dislocations in globally traded markets. The matter further surprised China hawks in Congress, who have been unimpressed by the administration's reassurances. Rep. John Moolenaar, the Michigan Republican who chairs the US House Select Committee on China, questioned the legal basis for the move and suggested it does an end-run around controls put in place to limit the sale of sensitive technology to US adversaries. 'Export controls are a front-line defense in protecting our national security, and we should not set a precedent that incentivizes the government to grant licenses to sell China technology that will enhance its AI capabilities,' he said. It also raises questions about where the administration will steer the revenue. Trump has mused about issuing tariff rebate checks — though he has yet to seriously pursue the idea — while at other times he's said it would go toward narrowing the large budget deficit. The administration had debated launching a sovereign wealth fund before shelving those plans for now. It's too soon to say whether the administration will seek to revive the fund and steer revenue there, one official familiar with deliberations said. 'Trump's aides argue that these measures will strengthen America's AI leadership by maximizing its global influence and market share,' Hal Brands, a professor at the Johns Hopkins School of Advanced International Studies and a former Pentagon official, wrote in Bloomberg Opinion. 'Yet it is also possible that they will simply eat into America's innovation advantage.' --With assistance from Mackenzie Hawkins and Derek Wallbank. (Updates with details of consultation process in fifth paragraph.) Americans Are Getting Priced Out of Homeownership at Record Rates Dubai's Housing Boom Is Stoking Fears of Another Crash Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Why It's Actually a Good Time to Buy a House, According to a Zillow Economist The Electric Pickup Truck Boom Turned Into a Big Bust ©2025 Bloomberg L.P. Sign in to access your portfolio
Business Insider
6 hours ago
- Business Insider
Goldman Sachs Reaffirms Their Hold Rating on CoreWeave, Inc. Class A (CRWV)
In a report released today, Kash Rangan from Goldman Sachs maintained a Hold rating on CoreWeave, Inc. Class A, with a price target of $120.00. The company's shares closed today at $117.76. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Rangan covers the Technology sector, focusing on stocks such as Snowflake, Microsoft, and CoreWeave, Inc. Class A. According to TipRanks, Rangan has an average return of 6.5% and a 52.92% success rate on recommended stocks. In addition to Goldman Sachs, CoreWeave, Inc. Class A also received a Hold from Bank of America Securities's Bradley Sills in a report issued today. However, on the same day, Jefferies maintained a Buy rating on CoreWeave, Inc. Class A (NASDAQ: CRWV). Based on CoreWeave, Inc. Class A's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $981.63 million and a GAAP net loss of $314.64 million. In comparison, last year the company earned a revenue of $116 million and had a GAAP net loss of $170.57 million
